Investment Rating - The industry investment rating is "Buy" [3] Core Insights - The Q4 predetermined interest rate research value is 1.89%, indicating that product predetermined rates remain stable [6] - The insurance industry is expected to see a marginal improvement in the "interest and expense difference" due to regulatory guidance aimed at reducing liability costs and potential increases in asset yields [6] - The dynamic adjustment mechanism for predetermined rates and the transformation of participating insurance are expected to drive down the rigid liability costs of new policies, leading to a turning point for existing liability costs [6] - The report suggests focusing on the insurance sector, with specific stock recommendations including China Ping An, China Life, China Taiping, and others [6] Summary by Sections Industry Overview - The Q4 predetermined interest rate research value is 1.89%, which does not meet the conditions for a rate reduction, as it is only 11 basis points lower than the current traditional insurance predetermined rate of 2.0% [6] - The expected stability of the predetermined interest rate is projected to continue into Q1 2026, with an estimated value of around 1.9% [6] Regulatory Environment - The China Insurance Industry Association has set guidelines for adjusting predetermined rates, which require a 25 basis point difference over two consecutive quarters to trigger a reduction [6] - The report highlights the importance of the 10-year government bond yield as a key indicator influencing the research value [6] Investment Recommendations - The report recommends focusing on the insurance sector, particularly companies such as China Ping An (A/H), China Life (A/H), China Taiping (H), and others, due to expected improvements in profitability margins [6][7]

1月21日，智通财经从中国人寿集团获悉，截至2025年12月31日，中国人寿海外公司总资产已超过4528 亿港元。 据了解，在香港特区政府于2025年11月发行的多币种数码绿色债券中，中国人寿海外公司参与美元、离 岸人民币、港元及欧元四个币种的认购，合计约24亿港元等值资金，成为中资保险最大认购方。同期， 中国财政部在港发行40亿美元3年期和5年期美元主权债券，中国人寿海外公司认购约6亿美元。 在股权投资方面，2025年中国人寿海外公司参与多宗香港H股IPO项目，涵盖半导体、人工智能、生物 医药等领域。其中，禾赛科技、MiniMax及维升药业等企业已在香港联交所上市。 ...

Core Viewpoint - The core indicator for pricing life insurance products, the predetermined interest rate research value, has been updated to 1.89%, marking a continuous decline over four quarters since the dynamic adjustment mechanism was implemented in January 2025, with the rate decreasing from 2.34% to 2.13%, 1.99%, and 1.90%, with the latest adjustment being a minor drop of 1 basis point, indicating a shift from rapid decline to moderate stabilization [1][2][11]. Group 1: Predetermined Interest Rate Dynamics - The current predetermined interest rate research value is 1.89%, and the upper limit for ordinary life insurance has been reduced from 2.5% to 2% [3][12]. - The adjustment mechanism stipulates that a reduction in the predetermined interest rate is only necessary if the upper limit exceeds the research value by 25 basis points for two consecutive quarters; currently, the difference is only 11 basis points, not triggering a reduction [1][2][12]. - If the research value remains below 1.75% for the first two quarters of 2026, the earliest adjustment could occur in the third quarter of 2026, making the first half of 2026 a critical observation period [1][2][12]. Group 2: Market and Economic Context - The macroeconomic environment shows a continued decline in interest rates, with the 10-year government bond yield rising by 25 basis points to 1.85% in 2025, ending a four-year downward trend, although this level remains historically low [3][12]. - The 5-year LPR has remained stable at 3.5% for eight consecutive months, while some banks have lowered their 5-year fixed deposit rates to between 1.3% and 1.8%, further reducing the yield of similar savings products [4][12]. - Recent structural interest rate cuts by the central bank, including a 0.25 percentage point reduction in various lending rates, signal a potential easing of monetary policy, although it may not immediately affect the LPR [4][13]. Group 3: Industry Growth and Trends - The life insurance sector is experiencing a robust start to 2026, with many companies reporting double-digit growth in new premium income, driven by a shift in consumer preference towards stable, low-risk investment options amid a low-interest-rate environment [6][16][17]. - Major insurers like China Life and Ping An have reported new premium income growth exceeding 70%, with China Life's new premium income increasing by 76% from New Year's Day to mid-January [17]. - The insurance industry is transitioning from merely being a financial product to becoming a core component of family wealth planning and lifelong social security, emphasizing the integration of long-term returns and protection features in product offerings [8][16][17].

Core Viewpoint - China Life Overseas Company has established itself as a leading Chinese insurance company and institutional investor in the Hong Kong and Macau regions, with total assets exceeding 452.8 billion HKD [1] Group 1: Company Overview - China Life Overseas Company is the only wholly-owned subsidiary of China Life Insurance (Group) Company operating overseas [1] - The company’s business encompasses life insurance, savings insurance, annuities, and mandatory provident funds [1] Group 2: Market Participation - The company actively supports the Hong Kong government and the Ministry of Finance of China in issuing government bonds in Hong Kong, thereby enhancing the influence of the Hong Kong bond market [1] - In November 2025, the Hong Kong SAR government will issue multi-currency digital green bonds, including USD, offshore RMB, HKD, and EUR bonds, with China Life Overseas Company participating in all four currency bond subscriptions, totaling approximately 2.4 billion HKD [1] Group 3: Investment Activities - In 2025, China Life Overseas Company will participate in multiple Hong Kong H-share IPOs, supporting the Stock Exchange's Chapter 18A regulations that allow unprofitable biotech companies to list [1] - The company is actively investing in hot sectors such as semiconductors, AI, and healthcare, supporting outstanding Chinese enterprises in achieving reasonable pricing during IPOs and contributing to the prosperity of the Hong Kong financial market [1] - Through various private equity funds focused on semiconductors, AI, and healthcare, the company is involved in equity investments in several star innovative enterprises [1]

21世纪经济报道记者卢陶然、李德尚玉 北京报道 距离2026年A股上市公司ESG首次"大考"仅剩3个月，上市险企的ESG成绩单备受市场关注。 截至2026年1月21日，中国人寿、中国平安、中国太保、中国人保、新华保险等5家A股上市险企，已全 部被纳入交易所规定的ESG强信披范围，需要在未来3个月内披露最新年度ESG报告。 与此同时，随着我国首部金融ESG评价国标发布，保险业ESG有了明确的"评分标准"。近日，由中国人 民银行指导、中央国债登记结算有限责任公司起草的《债券发行人环境、社会和治理评价框架》国标发 布。 据21世纪经济报道记者梳理，在5家险企披露的2024年ESG报告中，所有险企的年度总碳排放下行趋势 明显，降幅最高达12.5%；5家险企的绿色投资规模达1万亿元。与之形成对比的是客户服务领域的隐 忧，新华保险投诉总量同比激增71.52%，险企中人身险公司投诉量占比达62.4%。 业内人士向21世纪经济报道记者表示，险企不仅需要优化自身碳管理，更需通过绿色投资引导实体经济 转型，在平衡环境效益与社会责任中寻找可持续发展新路径。随着ESG大考进入倒计时，险企需要在保 持碳减排成效的同时，尽快补齐ESG披 ...

Core Insights - The Brand Finance 2026 Global Brand Value 500 report was released on January 20, 2026, in Davos, Switzerland, highlighting the performance of various brands globally [1][5]. Group 1: Chinese Brands Performance - A total of 68 Chinese brands made it to the list, with the insurance sector showing strong performance, featuring 7 insurance companies [1][5]. - The top Chinese insurance brands included Ping An (32nd), China Life Insurance (104th), and China People's Insurance (145th) [1][5]. - Among the 7 insurance brands, 6 experienced an increase in brand value, with China People's Insurance seeing a significant growth of 12%, reaching a brand value of $16.82 billion and moving up 5 places to rank 145th globally [1][5]. Group 2: Brand Rankings and Values - Notable rankings include Douyin at 6th with a brand value of $153.54 billion, State Grid at 10th with $102.44 billion, and ICBC at 12th with $90.88 billion [2][6]. - Other significant brands include China Construction Bank (14th), Bank of China (17th), and Agricultural Bank of China (19th), all maintaining strong brand values and ratings [2][6]. - The report indicates that the brand strength scores and ratings for these companies reflect their competitive positioning in the market, with many achieving AAA or AA ratings [2][6].

据统计，南下资金已连续8日净买入阿里，共计58.3455亿港元；连续4日净买入小米，共计20.1881亿港 元；连续13日净卖出中国移动，共计102.2037亿港元。(格隆汇) 格隆汇1月21日｜南下资金今日净买入港股139.3亿港元。其中： 净买入盈富基金41.53亿、恒生中国企业18.17亿、阿里巴巴-W 10.78亿、中国人寿10.08亿、快手-W 7.33 亿、小米集团-W 5.89亿、中芯国际3.87亿、中国海洋石油3.64亿、山东黄金3.03亿、美团-W 2.04亿、 净卖出中国移动9.21亿、腾讯控股2.71亿、华虹半导体1.2亿。 | | 沪股通 | | | 深股通 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 潔跌幅 | 净买入额(亿) | 成交额 | 名称 | 涨跌幅 | 净买入额(亿) | 成交割 | | 阿里巴巴-W | 2.2% | 9.45 | 42.24 Z | 腾讯控股 | 0.3% | -3.01 | 25.58 Z | | 小米集团-W | -0.2% | 3.08 | 41.87 Z | ...

Core Insights - The insurance sector has seen a significant surge in new business through the bancassurance channel, with nearly 40 life insurance companies reporting a total new business scale exceeding 71.1 billion yuan, marking a substantial year-on-year increase [1][5] - The driving force behind this growth is attributed to the ongoing low interest rate environment, which has diminished the attractiveness of traditional deposits, prompting funds to seek alternative investment channels [6][8] Group 1: Market Dynamics - The bancassurance channel has successfully captured a large volume of funds that are looking for new outlets due to the declining interest rates, with the one-year and above fixed deposit maturity amount reaching 50 trillion yuan in 2026 [2][6] - The appeal of bancassurance products has been amplified in the context of low deposit rates, with standard products offering a maximum guaranteed interest rate of 2.0% and participating products providing a minimum return of 1.75% plus floating dividends [2][6] Group 2: Policy and Structural Changes - Recent policy adjustments, including the integration of insurance and banking services, have facilitated the growth of the bancassurance channel, allowing it to surpass individual insurance as the leading distribution channel in the first half of 2025 [3][7] - The growth in bancassurance premiums has translated into increased commission earnings for customer managers, enhancing customer retention and providing banks with a stable source of funds [7][8] Group 3: Future Outlook - The bancassurance channel's performance in 2026 is expected to be a result of both the low interest rate environment and the structural changes within the banking sector, with projections indicating that new business premium growth for listed insurance companies through this channel could exceed 30% [4][8]

证券之星消息，1月21日保险板块较上一交易日下跌1.03%，中国人保领跌。当日上证指数报收于 4116.94，上涨0.08%。深证成指报收于14255.12，上涨0.7%。保险板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 601628 | 中国人寿 | 47.92 | -0.77% | 18.57万 | 8.95 Z | | 601601 | 中国太保 | 43.90 | -0.79% | 37.81万 | 16.67亿 | | 601318 | 中国平安 | 65.85 | -1.13% | 93.54万 | 266619 | | 601336 | 新华保险 | 79.80 | -1.31% | 16.73万 | 13.41亿 | | 61319 | 中国人保 | 9.17 | -1.71% | 70.81万 | 6.5317 | | 代码 | 名称 | 主力净流入 (元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 ...

在投资领域，中国人寿海外公司投资策略注重风险管理和长期价值创造，为中国香港国际金融中心的可 持续发展注入强劲动力。 据了解，2025年11月香港特区政府发行多币种数码绿色债券，包括美元债、离岸人民币债、港元债及欧 元债。中国人寿海外公司参与全部四个币种债券认购，合计约24亿等值港元，成为中资保险最大认购 方。 2025年，中国人寿海外公司参与了多宗香港H股IPO，支持联交所18A章程（允许未盈利生物科技公司 上市），积极投资半导体、AI、医疗等热点领域企业，支持优秀中资企业在IPO中获得合理定价。 据悉，中国人寿海外公司还通过半导体、AI、医疗等赛道的多只私募股权基金，积极参与到多个明星 创新企业的股权投资，其中包括2025年9月在香港联交所主板挂牌上市的禾赛科技（02525.HK），2026 年1月在香港联交所挂牌上市的"AI大模型第一股"——MiniMax（00100.HK）。 （文章来源：中国经营报） 2026年1月20日，《中国经营报》记者从中国人寿集团获悉，截至2025年12月31日，中国人寿海外公司 总资产已超过4528亿港元。 ...